Urologic Oncologist at NCI | Assoc Prof & Fellowship APD | #kidneycancer #pheo surgery & translational genomics 🧬 Views mine
Joined June 2010
- Tweets 1,459
- Following 585
- Followers 2,978
- Likes 5,764
243 Photos and videos
Pinned Tweet
9 Jul 2022
So great to meet all of the residents at @AmerUrological #AUAFundamentals today and to discuss #KidneyCancer.
My @michaelpollan inspired approach to kidney tumors:
5
10
76
Mark Ball, MD, FACS retweeted
Apr 29
Thank you to our 3,000 followers for engaging with Urologic Oncology: Seminars and Original Investigations. Your support helps amplify important work in urologic cancer research, education, and collaboration.
@markballmd @SUO_YUO @UroOnc
1
2
11
1,751
Mark Ball, MD, FACS retweeted
Mar 26
🔥The April 2026 issue of 'Urologic Oncology: Seminars and Original Investigations' is now available.
Click here to stay on top of urologic oncology ▶️ bit.ly/4sGg0s8
#NowOnline #UroSoMe #MedTwitt
3
6
989
Mar 10
NCI Urologic Oncolgy Branch is still accepting @SUO_YUO fellowship applications - interviews April 13, 14, 20. DM or email margot.michels@nih.gov for more information.
5
15
2,777
Mark Ball, MD, FACS retweeted
Feb 16
Unraveling smooth muscle-rich #RenalCellCarcinoma: Clinical, oncological, genetic, and pathological insights. #AuthorCommentary
Smooth muscle–rich #RCC is a rare but distinct entity. In the largest cohort to date, smrRCC showed frequent bilateral multifocal disease, unique genetic features, and rare metastatic potential—highlighting the need for genetic testing, surveillance, and nephron-sparing care. #ReadMore on UroToday > bit.ly/464Vech @RubenBlachmanMD @MillanBraden @markballmd @theNCI @urogoldjournal
4
11
1,271
I’ve spent my entire professional career as a cancer surgeon fighting cancer in the OR.
This spring, I’m taking that fight to the mats. 🥋🎗️
Proud to compete in Tap Cancer Out Baltimore on May 9, 2026, representing Culture of Jiu Jitsu Academy.
I'm asking for your help. Please donate below and support the fight:
wecan.tapcancerout.org/fundr…
#TapCancerOut #RollToEndCancer #BJJForACause
3
22
1,511
A familiar face returns, wiser in years and rich in scholarship. Welcome back @PGomellaMD, to UOB grand rounds on Genetics of Prostate Cancer.
2
13
2,361
Mark Ball, MD, FACS retweeted
Jan 21
Unraveling smooth muscle-rich #RenalCellCarcinoma: Clinical, oncological, genetic, and pathological insights. #AuthorCommentary
Smooth muscle–rich #RCC is a rare but distinct entity. In the largest cohort to date, smrRCC showed frequent bilateral multifocal disease, unique genetic features, and rare metastatic potential—highlighting the need for genetic testing, surveillance, and nephron-sparing care. #ReadMore on UroToday > bit.ly/464Vech @RubenBlachmanMD @MillanBraden @markballmd @theNCI @urogoldjournal
1
12
740
Mark Ball, MD, FACS retweeted
4 Dec 2025
Congratulations to @UrolOncol 2025 Best Reviewers!
#SUO2025 @SUO_YUO @UroOnc
@VikramNarayan @LauraBukavinaMD @therealUroJET @TaylorGoodstein @rezanab @PCuroMD @abetakashige
1
6
34
3,828
Mark Ball, MD, FACS retweeted
20 Sep 2025
The editorial team of Urologic Oncology extends its sincere appreciation to our peer reviewers who have completed over 100 manuscript reviews. Their dedication of time, depth of expertise, and thoughtful insight strengthen the journal’s quality and help advance the field.
9
43
9,453
8 Oct 2025
What a treat to chat with these three kidney cancer thought leaders.
8 Oct 2025
Kidney cancer management is evolving - how are experts adapting? Dr. Brandon Manley, @Raquib_Hannan, & @DrRanaMcKay join @markballmd for a multidisciplinary discussion on kidney cancer care @_backtableONC #URO263
This episode is supported by: @ferring
na2.hubs.ly/H01sNx90
ALT Ep 263 Renal Cancer Management: Tumor Board Discussion & Treatments with Dr. Raquib Hannan, Dr. Brandon Manley and Dr. Rana McKay
1
3
12
2,171
Mark Ball, MD, FACS retweeted
1 Oct 2025
Kidney cancer management is evolving. How are experts adapting?
In this installment of BackTable Tumor Board, Dr. Brandon Manley, Dr. Raquibul Hannan, and Dr. Rana McKay join guest host Dr. Mark Ball to share their multidisciplinary perspectives on challenging, real-world kidney cancer cases.
This podcast is supported by: Ferring Pharmaceuticals
Watch the episode here: na2.hubs.ly/H01mb5Q0
#ONC23 #kidneycancer #oncology #urology
3
6
1,224
Mark Ball, MD, FACS retweeted
16 Sep 2025
MRI features can distinguish benign from malignant HLRCC-associated renal cysts. Our model could spare >50% of patients with benign cysts from unnecessary surgery.
Huge thanks to my PI @aamalayeri and our amazing team @aryanzg @NIHClinicalCntr !
rdcu.be/eGH9z
1
15
930
Mark Ball, MD, FACS retweeted
1 Sep 2025
📢Published in the September issue of @UrolOncol
Feasibility and perioperative outcomes of re-operative retroperitoneal robotic partial nephrectomy
Click here to read the article▶️bit.ly/3I49TM9
#UroSoMe #MedTwitter #kidneycancer
4
11
1,175
Mark Ball, MD, FACS retweeted
7 Aug 2025
🚨Publication alert in @UrolOncol!
Urinary leak after partial nephrectomy: Insights from a cohort with hereditary, multifocal, and reoperative cases
@RubenBlachmanMD @markballmd
Click to read the article▶️ bit.ly/4m9yxd6
4
28
2,077
25 Jul 2025
New edition of Campbell’s has arrived, with touching tribute to Alan Partin. @ElsevierConnect @brady_urology
1
5
62
3,040
Mark Ball, MD, FACS retweeted
18 Jul 2025
That's a wrap on #KCRS25!
Thank you to everyone who joined us, whether you were with us in Boston or tuning in virtually from around the world. Your presence, questions, and passion for collaboration made this year’s summit one to remember. Until next time, keep pushing the science forward.
#AcceleratingCures
1
8
32
1,896
18 Jul 2025
#KCRS25 is an amazing meeting for many reasons, but watching an illustrator draw your talk as you give it very cool.
6
23
1,428